Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Grant or award Director acquired 3,000 shares (grant or award)
  2. 4 Grant or award Director acquired 3,000 shares (grant or award)
  3. 4 Open-market sale VP, Controller and PAO sold 955 shares at $83.70 ($79,934)
  4. 4 Open-market sale VP, Controller and PAO sold 1,338 shares at $76.97 ($102,986)
  5. 4 Open-market sale CFO & Executive Vice President sold 6,700 shares at $80.07 ($536,456)
  6. 4 Shares withheld for taxes CFO & Executive Vice President gave up 346 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP & Chief Tech Ops Officer gave up 260 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 294 shares (to pay taxes)
  9. 4 Shares withheld for taxes CBO & EVP gave up 346 shares (to pay taxes)
  10. 4 Shares withheld for taxes President & CEO gave up 926 shares (to pay taxes)
  11. 4 Shares withheld for taxes Pinion John Richard gave up 260 shares (to pay taxes)
  12. 4 Open-market sale CFO & Executive Vice President sold 13,000 shares at $70.17 ($912,171)
  13. 4 Open-market sale Director sold 6,319 shares at $72.00 ($454,969)
  14. 4 Shares withheld for taxes VP, Controller and PAO gave up 433 shares (to pay taxes)
  15. 4 Shares withheld for taxes CFO & Executive Vice President gave up 381 shares (to pay taxes)
  16. 4 Shares withheld for taxes CBO & EVP gave up 381 shares (to pay taxes)
  17. 4 Shares withheld for taxes VP, Controller and PAO gave up 156 shares (to pay taxes)
  18. 4 Shares withheld for taxes President & CEO gave up 986 shares (to pay taxes)
  19. 4 Open-market sale EVP and General Counsel sold 1,465 shares at $60.00 ($87,900)
  20. 4 Insider Changes in Ownership

Page 21 of 32 · 627 filings